NCT02917668

Brief Summary

This study aims to evaluate the risk of hyperoxia-induced hypercapnia in post-op obese cardiac surgery patients. It will compare two oxygenation modes in terms of their effect on the arterial partial pressure of carbon dioxide (PaCO2) : manual titration of oxygen delivery for a peripheral oxygen saturation (SpO2) target of \> or = 95 % versus automatic titration by a closed-loop system for a SpO2 target of 90%. 15 post-op obese cardiac surgery patients will be recruited and each will receive both interventions (cross-over design). The main outcome will be the PaCO2, which will be compared after each study period. The research hypothesis is that the usual SpO2 target of \> or = 95 % is associated with a greater PaCO2 compared with a lesser SpO2 target of 90%.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Sep 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

September 25, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 28, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2018

Completed
Last Updated

May 11, 2018

Status Verified

May 1, 2018

Enrollment Period

1.4 years

First QC Date

September 25, 2016

Last Update Submit

May 5, 2018

Conditions

Keywords

ObesityHyperoxiaHypercapniaPostoperative complicationsCardiac surgical procedures

Outcome Measures

Primary Outcomes (1)

  • Difference in PaCO2

    Difference in end-of-period PaCO2 on arterial blood gas

    At 30 minutes (first intervention) and at 1h (second intervention)

Secondary Outcomes (11)

  • Difference in pH

    At 30 minutes (first intervention) and at 1h (second intervention)

  • Difference in PaO2

    At 30 minutes (first intervention) and at 1h (second intervention)

  • Difference in percentage of time spent in hypoxemia (SpO2 < 88%)

    In the first 30 minutes (first intervention) and between 30 min and 1h (second intervention)

  • Difference in percentage of time spent in severe hypoxemia (SpO2 < 85 %)

    In the first 30 minutes (first intervention) and between 30 min and 1h (second intervention)

  • Difference in percentage of time spent in hyperoxemia (SpO2 > 96 %)

    In the first 30 minutes (first intervention) and between 30 min and 1h (second intervention)

  • +6 more secondary outcomes

Study Arms (2)

Group A

ACTIVE COMPARATOR

15 patients who will receive usual care for 30 minutes and then switch to FreeO2 for another 30 minutes

Other: FreeO2Other: Usual care

Group B

ACTIVE COMPARATOR

15 patients who will be oxygenated by FreeO2 for 30 minutes and then switch to usual care for another 30 minutes

Other: FreeO2Other: Usual care

Interventions

FreeO2OTHER

Oxygen delivery automatically titrated by a closed-loop system that adjusts the oxygen flow based on the patient's real-time SpO2 and a programed SpO2 target of 90 %

Group AGroup B

Oxygen delivery manually titrated by the nursing staff for a SpO2 target of \> or = 95 %

Group AGroup B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI \> 30 kg/m2
  • SpO2 \> or = 95 % before extubation
  • Procedure : coronary artery bypass

You may not qualify if:

  • Comorbidities : chronic obstructive pulmonary disease, cystic fibrosis, restrictive syndrome not associated with obesity (pulmonary fibrosis, neuromuscular junction disease, etc.)
  • Obstructive sleep apnea requiring a positive-pressure mask in the posteoperative period
  • FreeO2 device unavailable

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut universitaire de cardiologie et de pneumologie de Québec

Québec, G1V4G5, Canada

Location

Related Publications (4)

  • Beasley R, Chien J, Douglas J, Eastlake L, Farah C, King G, Moore R, Pilcher J, Richards M, Smith S, Walters H. Thoracic Society of Australia and New Zealand oxygen guidelines for acute oxygen use in adults: 'Swimming between the flags'. Respirology. 2015 Nov;20(8):1182-91. doi: 10.1111/resp.12620.

    PMID: 26486092BACKGROUND
  • O'Driscoll BR, Howard LS, Davison AG; British Thoracic Society. BTS guideline for emergency oxygen use in adult patients. Thorax. 2008 Oct;63 Suppl 6:vi1-68. doi: 10.1136/thx.2008.102947. No abstract available.

    PMID: 18838559BACKGROUND
  • Lellouche F, L'her E. Automated oxygen flow titration to maintain constant oxygenation. Respir Care. 2012 Aug;57(8):1254-62. doi: 10.4187/respcare.01343. Epub 2012 Feb 17.

    PMID: 22348812BACKGROUND
  • Denault MH, Ruel C, Simon M, Bouchard PA, Simard S, Lellouche F. Evaluation of hyperoxia-induced hypercapnia in obese patients after cardiac surgery: a randomized crossover comparison of conservative and liberal oxygen administration. Can J Anaesth. 2020 Feb;67(2):194-202. doi: 10.1007/s12630-019-01500-x. Epub 2019 Oct 24.

MeSH Terms

Conditions

ObesityHyperoxiaHypercapniaPostoperative Complications

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratoryPathologic Processes

Study Officials

  • François Lellouche, MD, PhD

    Laval University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

September 25, 2016

First Posted

September 28, 2016

Study Start

September 1, 2016

Primary Completion

January 8, 2018

Study Completion

January 8, 2018

Last Updated

May 11, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will share

The investigators would like to publish our results in scientific magazine and/or present them in a Conference.

Locations